Fund Holdings — Kynam Capital Management, LP

Total Portfolio Value:
$1.29B
Total Bought:
$344.12M
Total Sold:
$33.42M
Net Transaction:
+$310.71M
Notable People:
Kynam Capital Management Gp,
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Natera, Inc.(NTRA)2,014,4082,042,471+28,063$218.14M$259.29M20.09%+$41.15M
Vaxcyte, Inc.(PCVX)753,2401,039,288+286,048$56.88M$118.76M9.20%+$61.88M
Celldex Therapeutics, Inc.(CLDX)3,388,9673,458,609+69,642$125.43M$117.56M9.11%-$7.87M
Syndax Pharmaceuticals, Inc.(SNDX)5,722,0575,842,925+120,868$117.47M$112.48M8.72%-$5.00M
Cogent Biosciences, Inc.(COGT)9,260,3859,239,731-20,654$78.07M$99.79M7.73%+$21.72M
Dynavax Technologies Corp7,082,5628,332,687+1,250,125$79.54M$92.83M7.19%+$13.29M
Vera Therapeutics, Inc.CL A(VERA)1,543,6691,576,549+32,880$55.85M$69.68M5.40%+$13.83M
BioCryst Pharmaceuticals, Inc.(BCRX)8,826,7109,085,368+258,658$54.55M$69.05M5.35%+$14.50M
CG Oncology, Inc.(CGON)53,9111,770,805+1,716,894$1.70M$66.81M5.18%+$65.11M
Viridian Therapeutics, Inc.(VRDN)1,750,0002,511,295+761,295$22.77M$57.13M4.43%+$34.36M
Wave Life Sciences, Inc.SHS(WVE)3,975,5214,899,497+923,976$19.84M$40.18M3.11%+$20.34M
Beam Therapeutics Inc.(BEAM)01,302,085+1,302,085$0$31.90M2.47%+$31.90M
2seventy Bio Inc5,953,8255,953,8250$22.92M$28.10M2.18%+$5.18M
Liquidia Corporation(LQDA)916,5742,266,328+1,349,754$11.00M$22.66M1.76%+$11.66M
Protagonist Therapeutics Inc800,000456,369-343,631$27.72M$20.54M1.59%-$7.18M
Travere Therapeutics, Inc.(TVTX)2,021,6591,371,511-650,148$16.62M$19.19M1.49%+$2.57M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)1,641,8913,685,563+2,043,672$10.71M$15.18M1.18%+$4.48M
Engene Holdings Inc
COM
01,736,227+1,736,227$0$11.46M0.89%+$11.46M
Tyra Biosciences, Inc.(TYRA)566,715467,947-98,768$9.06M$11.00M0.85%+$1.94M
Amarin Corp PlcADR12,155,83012,414,628+258,798$8.36M$7.78M0.60%-$580.5K
Sutro Biopharma, Inc.(STRO)2,023,6832,066,447+42,764$5.93M$7.15M0.55%+$1.22M
Caribou Biosciences, Inc.(CRBU)1,646,7022,356,147+709,445$2.70M$4.62M0.36%+$1.92M
Acelyrin Inc831,310847,366+16,056$3.67M$4.18M0.32%+$511.4K
Burning Rock Biotech LimitedADS(BNR)974,668989,217+14,549$6.28M$3.23M0.25%-$3.05M
Page 1 of 1
Kynam Capital Management, LP — 13F Holdings — Q3 2024 | TickerTrail